Rhode Island Mobile Methadone Treatment Faces Funding Strain

Since July 2022, a mobile methadone treatment unit has been dispensing medication six days a week in Woonsocket, Rhode Island. A new study published in Addiction Science and Clinical Practice interviewed the people who run it.

The picture it produces is of a program that reaches patients the fixed clinic system does not. Unfortunately, that could stop running for reasons unrelated to whether it works.

The timing matters because of the fact that this model is spreading. Federally approved methadone mobile units in the United States have grown from just 8 in 2022 to 64 by early 2025. This was after the Drug Enforcement Administration reversed a moratorium that had blocked expansion since 2007.

What the Study Examined

Researchers led by Augustine Kang of Boston Children’s Hospital and Amelia Bailey of the Brown University School of Public Health studied a unit launched by CODAC Behavioral Healthcare. It is Rhode Island’s largest provider of opioid treatment services.

The unit runs in two capacities. It operates as a fully licensed opioid treatment program, prescribing and dispensing medication six days a week in Woonsocket. It’s a city the study describes as having one of the highest per capita overdose rates in the state. It also functions as a community outreach service by delivering harm reduction supplies and counseling.

The team conducted semi-structured qualitative interviews with 15 stakeholders between the months of August and November 2024. Participants included unit staff and clinicians, staff from CODAC’s fixed-site clinics, organizational leadership, community partners and a representative of the State Opioid Treatment Authority.

Why Medical Supervision Still Anchors the Model

Methadone is a long-acting full opioid agonist used to treat opioid use disorder. It suppresses withdrawal and blunts cravings without the swings of short-acting opioids.

But it carries real overdose and interaction risk and must be dispensed through a licensed opioid treatment program. That is why the mobile unit is licensed as an opioid treatment program and not as a general outreach van.

Federal rules require in-person contact to start methadone treatment. For people who are unhoused or moving frequently, that requirement can be a major barrier. Participants described the unit as dissolving it by bringing dosing, assessment and intake directly into the neighborhoods where patients already are.

What Stakeholders Said Works

Participants pointed to reach first. The unit connects with people facing homelessness, economic instability and the transportation barriers that make daily clinic visits impractical.

The unit also works as a broader health access point. Staff described blood pressure checks, wound care, clean needle and wound kits, and referrals to primary care for unmanaged conditions such as hypertension and diabetes.

The authors note this integrated approach aligns with research showing that combining medication for opioid use disorder with primary care improves retention and health outcomes.

Relationships came up repeatedly. Unlike conventional clinics where participants described a pattern of arriving, dosing and leaving, the compact mobile setting let staff learn names and build rapport.

Participants credited that familiarity with keeping people involved during periods of active use. Small gift cards drew people in early on but staff reported that external motivation gave way to internal motivation over time. The ability to earn take-home doses emerged as one of the strongest retention tools.

What Threatens Mobile Methadone Treatment

Staffing shortages surfaced in nearly every interview about the mobile methadone treatment program. The unit is not fully staffed and counseling and case management are handled by staff rotated in from Providence rather than a dedicated mobile team.

Low health insurance reimbursement rates and the uncertainty of grant funding left participants worried about whether the unit survives long term. The vehicle imposes limits.

There is one enclosed office for private conversations, with counseling elsewhere conducted behind dividers and sound machines. Weather created its own problem. After patients were found waiting in freezing snow, the unit changed policy to provide take-home doses whenever snow was forecast.

External resistance proved substantial. Stakeholders described municipal officials attempting to use zoning ordinances to shut down services in one community, which required legal intervention.

Law enforcement activity near treatment sites, including traffic stops targeting patients arriving for care, forced some people to weigh arrest risk against their need for medication. The study also documents a counter-trend.

Through proactive engagement, staff built relationships with police departments and in some cases officers began referring people to the unit rather than arresting them.

Finding Medical Detox and Medication Assisted Treatment

Mobile units are one access route and not a replacement for the full continuum of care. The practical questions are whether a program is licensed, which medications it offers, how quickly it can start treatment and what happens after the first dose.

The authors flag one limitation. No patients were interviewed directly. Findings about patient experience reflect staff and stakeholder perceptions. They also cite a recent scoping review finding that mobile units remain underutilized.

Detox.com can help you find medically supervised detox and medication-assisted treatment programs in your area. Call 800-996-6135(Sponsored) to speak with someone about treatment options near you.